These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23714350)

  • 1. Pharmacologic issues of antiretroviral agents and immunosuppressive regimens in HIV-infected solid organ transplant recipients.
    Primeggia J; Timpone JG; Kumar PN
    Infect Dis Clin North Am; 2013 Jun; 27(2):473-86. PubMed ID: 23714350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral and immunosuppressive drug-drug interactions in human immunodeficiency virus-infected liver and kidney transplant recipients.
    Marfo K; Greenstein S
    Transplant Proc; 2009 Nov; 41(9):3796-9. PubMed ID: 19917390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous pancreas-kidney transplantation in HIV-infected patients: a case report and literature review.
    Miro JM; Ricart MJ; Trullas JC; Cofan F; Cervera C; Brunet M; Tuset M; Manzardo C; Oppenheimer F; Moreno A
    Transplant Proc; 2010 Nov; 42(9):3887-91. PubMed ID: 21094878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kidney transplant in patients with HIV infection].
    Bossini N; Sandrini S; Valerio F
    G Ital Nefrol; 2012; 29(4):404-17. PubMed ID: 22843153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of immunosuppressive drugs on HIV infection: implications for solid-organ transplantation.
    Ciuffreda D; Pantaleo G; Pascual M
    Transpl Int; 2007 Aug; 20(8):649-58. PubMed ID: 17425723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interference among antiretroviral, anti-HCV, and immunosuppressive treatments].
    Peytavin G
    Med Mal Infect; 2004 Nov; 34 Spec No 2():20-1. PubMed ID: 15801535
    [No Abstract]   [Full Text] [Related]  

  • 7. Raltegravir-based highly active antiretroviral therapy has beneficial effects on the renal function of human immunodeficiency virus-infected patients after solid organ transplantation.
    Moreno A; Pérez-Elías MJ; Casado JL; Fortún J; Bárcena R; Quereda C; Del Campo S; Gutiérrez C; Pastor O; Nuño J; Fernandez A; Moreno S
    Liver Transpl; 2010 Apr; 16(4):530-2. PubMed ID: 20213666
    [No Abstract]   [Full Text] [Related]  

  • 8. Integrase strand transferase inhibitors: the preferred antiretroviral regimen in HIV-positive renal transplantation.
    Azar MM; Malinis MF; Moss J; Formica RN; Villanueva MS
    Int J STD AIDS; 2017 Apr; 28(5):447-458. PubMed ID: 27193421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid organ transplantation in HIV-infected recipients.
    El Sayegh S; Keller MJ; Huprikar S; Murphy B
    Pediatr Transplant; 2004 Jun; 8(3):214-21. PubMed ID: 15176956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-drug interaction in a kidney transplant recipient receiving HIV salvage therapy and tacrolimus.
    Mertz D; Battegay M; Marzolini C; Mayr M
    Am J Kidney Dis; 2009 Jul; 54(1):e1-4. PubMed ID: 19346040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloantigen-specific response is preserved and autoimmunity is maintained in an HIV-positive patient with immunoglobulin A nephropathy undergoing renal transplantation: a warning about long-term reduction in immunosuppression--a case report.
    Morales J; Alba A; Espinoza R; Sepúlveda C; Contreras L; Buckel E; Noriega L; Fierro JA
    Transplant Proc; 2011; 43(6):2341-3. PubMed ID: 21839266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of transplantation in HIV patients during the HAART era.
    Pelletier SJ; Norman SP; Christensen LL; Stock PG; Port FK; Merion RM
    Clin Transpl; 2004; ():63-82. PubMed ID: 16704139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infections in solid organ transplantation in special situations: HIV-infection and immigration.
    Miró JM; Blanes M; Norman F; Martín-Dávila P
    Enferm Infecc Microbiol Clin; 2012 Mar; 30 Suppl 2():76-85. PubMed ID: 22542039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver transplantation in HIV-infected recipients.
    Roland ME; Stock PG
    Semin Liver Dis; 2006 Aug; 26(3):273-84. PubMed ID: 16850377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-urgency priority heart transplantation in HIV-positive patients on life support: breaking barriers?
    Boignard A; Blanc M; Chavanon O
    J Heart Lung Transplant; 2011 Aug; 30(8):968-9. PubMed ID: 21531578
    [No Abstract]   [Full Text] [Related]  

  • 16. Nutritional and metabolic issues in solid organ transplantation: targets for future research.
    Ward HJ
    J Ren Nutr; 2009 Jan; 19(1):111-22. PubMed ID: 19121784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enfuvirtide: a safe and effective antiretroviral agent for human immunodeficiency virus-infected patients shortly after liver transplantation.
    Teicher E; Abbara C; Duclos-Vallée JC; Antonini T; Bonhomme-Faivre L; Desbois D; Samuel D; Vittecoq D
    Liver Transpl; 2009 Oct; 15(10):1336-42. PubMed ID: 19790146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid organ transplantation in HIV-infected individuals: obstacles and opportunities.
    Fishman JA; Rubin RH
    Transplant Proc; 2001; 33(1-2):1310-4. PubMed ID: 11267303
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-retrovirals and immunosuppressive drug interactions in a HIV-positive patient after liver transplantation.
    Antonini M; Ettorre GM; Vennarecci G; D'Offizi G; Narciso P; Del Nonno F; Perracchio L; Visco G; Santoro E
    Hepatogastroenterology; 2004; 51(57):646-8. PubMed ID: 15143883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patients.
    Jiménez-Nácher I; Alvarez E; Morello J; Rodriguez-Nóvoa S; de Andrés S; Soriano V
    Expert Opin Drug Metab Toxicol; 2011 Apr; 7(4):457-77. PubMed ID: 21342079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.